Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2150-9. doi: 10.1158/1055-9965.EPI-11-0344. Epub 2011 Jul 22.

Abstract

Background: Social determinants of prostate cancer survival and their relation to racial/ethnic disparities thereof are poorly understood. We analyzed whether census tract-level socioeconomic status (SES) at diagnosis is a prognostic factor in men with prostate cancer and helps explain racial/ethnic disparities in survival.

Methods: We used a retrospective cohort of 833 African American and white, non-Hispanic men diagnosed with prostate cancer at four Chicago area medical centers between 1986 and 1990. Tract-level concentrated disadvantage (CD), a multidimensional area-based measure of SES, was calculated for each case, using the 1990 U.S. census data. Its association with prostate cancer-specific survival was measured by using Cox proportional hazard models adjusted for case and tumor characteristics, treatment, and health care system [private sector vs. Veterans Health Administration (VA)].

Results: Tract-level CD associated with an increased risk of death from prostate cancer (highest vs. lowest quartile, HR = 2.37, P < 0.0001). However, the association was observed in the private sector and not in the VA (per 1 SD increase, HR = 1.33, P < 0.0001 and HR = 0.93, P = 0.46, respectively). The multivariate HR for African Americans before and after accounting for tract-level CD was 1.30 (P = 0.0036) and 0.96 (P = 0.82), respectively.

Conclusions: Census tract-level SES is a social determinant of prostate-specific mortality and helps account for racial/ethnic disparities in survival. An equal-access health care system may moderate this association.

Impact: This study identifies a potential pathway for minimizing disparities in prostate cancer control. The findings need confirmation in a population-based study.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Black or African American
  • Censuses
  • Chicago
  • Cohort Studies
  • Follow-Up Studies
  • Health Status Disparities*
  • Healthcare Disparities*
  • Humans
  • Male
  • Prognosis
  • Prostatic Neoplasms / ethnology
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / therapy
  • Retrospective Studies
  • Risk Factors
  • Social Class*
  • Survival Rate
  • White People